Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qimin Zhan

Showing results (71-80 of 242) with videos related to

Pageof 25
Sort By:
Signal Transduction and Targeted Therapy|February 14, 2022
Nuclear genome-derived circular RNA circPUM1 localizes in mitochondria and regulates oxidative phosphorylation in esophageal squamous cell carcinomaWei Gong, Jiancheng Xu, Yan Wang, et al.
Signal Transduction and Targeted Therapy|August 15, 2020
Membranous NOX5-derived ROS oxidizes and activates local Src to promote malignancy of tumor cellsJie Chen, Yan Wang, Weimin Zhang, et al.
Advances in Therapy|March 30, 2026
A Retrospective Observational Study of Safety and Effectiveness of Abemaciclib in Chinese Patients with Breast CancerFangyuan Zhao, Yaxin Liu, Hanfang Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2011
Role of Smac in determining the chemotherapeutic response of esophageal squamous cell carcinomaYang Xu, Lanping Zhou, Jing Huang, et al.
Molecular Carcinogenesis|December 7, 2020
Focal adhesion kinase (FAK) inhibitor-defactinib suppresses the malignant progression of human esophageal squamous cell carcinoma (ESCC) cells via effective blockade of PI3K/AKT axis and downstream molecular networkLingyuan Zhang, Di Zhao, Yan Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 27, 2018
Osthole inhibits the PI3K/AKT signaling pathway via activation of PTEN and induces cell cycle arrest and apoptosis in esophageal squamous cell carcinomaXinbing Zhu, Zhengzheng Li, Tongtong Li, et al.
Frontiers in Oncology|November 12, 2020
A Comprehensive Analysis of Alterations in DNA Damage Repair Pathways Reveals a Potential Way to Enhance the Radio-Sensitivity of Esophageal Squamous Cell CancerGuangchao Wang, Shichao Guo, Weimin Zhang, et al.
Cancer Letters|July 20, 2025
PAF signaling axis functions as biomarker or target for esophageal squamous cell carcinoma diagnosis or treatmentYanmeng Zhu, Fenglong Wang, Yuheng Zhu, et al.
Hepatology (Baltimore, Md.)|December 28, 2016
Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesisDan Li, Xuefeng Liu, Jian Zhou, et al.
Cellular & Molecular Immunology|August 12, 2022
Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC)Jie Chen, Di Zhao, Lingyuan Zhang, et al.
Pageof 25

Showing results (71-80 of 242) with videos related to

Sort By:
Pageof 25
Signal Transduction and Targeted Therapy|February 14, 2022
Nuclear genome-derived circular RNA circPUM1 localizes in mitochondria and regulates oxidative phosphorylation in esophageal squamous cell carcinomaWei Gong, Jiancheng Xu, Yan Wang, et al.
Signal Transduction and Targeted Therapy|August 15, 2020
Membranous NOX5-derived ROS oxidizes and activates local Src to promote malignancy of tumor cellsJie Chen, Yan Wang, Weimin Zhang, et al.
Advances in Therapy|March 30, 2026
A Retrospective Observational Study of Safety and Effectiveness of Abemaciclib in Chinese Patients with Breast CancerFangyuan Zhao, Yaxin Liu, Hanfang Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2011
Role of Smac in determining the chemotherapeutic response of esophageal squamous cell carcinomaYang Xu, Lanping Zhou, Jing Huang, et al.
Molecular Carcinogenesis|December 7, 2020
Focal adhesion kinase (FAK) inhibitor-defactinib suppresses the malignant progression of human esophageal squamous cell carcinoma (ESCC) cells via effective blockade of PI3K/AKT axis and downstream molecular networkLingyuan Zhang, Di Zhao, Yan Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 27, 2018
Osthole inhibits the PI3K/AKT signaling pathway via activation of PTEN and induces cell cycle arrest and apoptosis in esophageal squamous cell carcinomaXinbing Zhu, Zhengzheng Li, Tongtong Li, et al.
Frontiers in Oncology|November 12, 2020
A Comprehensive Analysis of Alterations in DNA Damage Repair Pathways Reveals a Potential Way to Enhance the Radio-Sensitivity of Esophageal Squamous Cell CancerGuangchao Wang, Shichao Guo, Weimin Zhang, et al.
Cancer Letters|July 20, 2025
PAF signaling axis functions as biomarker or target for esophageal squamous cell carcinoma diagnosis or treatmentYanmeng Zhu, Fenglong Wang, Yuheng Zhu, et al.
Hepatology (Baltimore, Md.)|December 28, 2016
Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesisDan Li, Xuefeng Liu, Jian Zhou, et al.
Cellular & Molecular Immunology|August 12, 2022
Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC)Jie Chen, Di Zhao, Lingyuan Zhang, et al.
Pageof 25